New guide highlights physiotherapy and AHP's role in maternity care
CSP members have contributed to a new educational guide that highlights the vital role physiotherapists and other allied health professionals (AHPs) play in maternity care.
Physical activity and lifestyle changes can reduce risk of dementia, says NICE
People can reduce their risk of developing dementia by exercising, becoming more active and making other healthy lifestyle changes.
Physio develops award-winning ‘Talking Work’ guide for GPs
A physiotherapist has developed an award-winning guide that aims to help GPs to have work related discussions with their patients.
Coming soon – Frontline July issue
The new issue of Frontline is out later this week.
Public Health England plan sets out how to achieve improved musculoskeletal health
The CSP is viewed as an ‘enabler’ for the delivery of a shared strategy supporting the prevention of musculoskeletal (MSK) conditions across England.
CSP encourages members to engage with statement supporting 'reflective practice'
A statement from the healthcare regulators on ‘reflective practice’ backs key arguments put forward by the CSP.
'Unique' rehabilitation exercise trial seeks participants with MS
People with multiple sclerosis (MS) are being sought to take part in a study that aims to investigate the benefits of a robotic walking device.
Birthday honours: Queen recognises the work of three physios and AHP lead for England
Three physiotherapists and England’s lead allied health professions officer received recognition in the Queen’s 2019 birthday honours list.
CSP director appointed to national workplace health and safety regulator board
Claire Sullivan, CSP’s director of Employment Relations and Union Services, has been appointed as non-executive director on the board of the Health and Safety Executive (HSE), Britain’s national regulator for workplace health and safety.
CSP welcomes regulatory body change to Dysport® licensing
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a product licence update for the botulinum toxin-A (BoNT-A) medicine Dysport® to make it clear that is can be administered by any appropriately trained and qualified healthcare professionals for the management of focal spasticity within licensed indications.